Table 1 General characteristics and description of patients with community-acquired pneumonia due to Enterobacter sp. compared to community-acquired-pneumonia due to common bacteria
EnterobacterCAP (n = 10) | CAP (n = 30) | |
|---|---|---|
Age (years) | 59.8 ± 20 | 64.3 ± 15.3 |
Male/female, % | 80/20 | 64/36 |
SAPS II | 44.9 ± 11.2 | 39 ± 13.3 |
SOFA/organ failure* | 5.7 ± 3.3/1.2 ± 1.1 | 4.9 ± 3.3/0.9 ± 1.1 |
Comorbidities, n | 1.7 ± 0.7 | 0.9 ± 0.8 |
COPD | 4 | 12 |
cancer or haematological disease | 4 | 6 |
diabetes mellitus | 4 | 5 |
neurological | 3 | 3 |
chronic heart failure | 1 | 3 |
chronic renal failure | 1 | 2 |
At least one comorbidity, % | 100 | 60 |
Smoking history, n | 3 | 11 |
Time between onset of symptoms and admission, days | 3 ± 2 | 3 ± 2.7 |
Symptoms, n | ||
T°>37.5°C | 7 | 22 |
highest temperature, °C | 39.6 ± 0.6 | 39.0 ± 1.0 |
chills | 1 | 5 |
sweating | 1 | 0 |
cough + sputum | 4 | 16 |
Acute onset$ /Progressive onset, n | 4/6 | 19/11 |
Sepsis classification, n (%) | ||
sepsis | 2 (20) | 10 (33) |
severe sepsis | 3 (30) | 12 (40) |
septic shock | 5 (50) | 8 (27) |
Leukocytosis (G/L) | 10.2 ± 4.8 | 15.1 ± 7.0 |
C-reactive protein (mg/dL) | 207 ± 150 | 202 ± 132 |
Blood urea (mmol/L) | 17.9 ± 12 | 10.3 ± 9.9 |
ARDS, n (%) | 8 (80) | 14 (47) |
At least one HCAP criterion ¤, n | 10 | 5 |